Why target PIM1 for cancer diagnosis and treatment?

Author： Magnuson Nancy S   Wang Zeping   Ding Gang   Reeves Raymond  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.9, 2010-09, pp. : 1461-1478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Review)

By Xie Yingqiu   Bayakhmetov Samat  

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 13-17

Science Publishers

Access to resources Recommend Favorite

Downregulation of microRNA33a promotes cyclindependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation

By                  

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6491-6500

Spandidos Publications

Access to resources Recommend Favorite

HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer

By Wang Yu   Wang Hongli   Song Tiefang   Zou Yiting   Jiang Jing   Fang Lei   Li Peiling  

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-08 ,pp. : 2211-2216

Spandidos Publications

Access to resources Recommend Favorite

The Proteasome as a Target for Cancer Treatment: Focus on Bortezomib

By Papandreou Christos N.  

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite

Transcriptional Regulation of Survivin: New Target for Cancer Treatment

By  

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-01 ,pp. : 331-339

Bentham Science Publishers

Access to resources Recommend Favorite